MX2016006882A - Nutricion infantil para el mejoramiento en la sensibilidad a la insulina mas adelante en la vida. - Google Patents
Nutricion infantil para el mejoramiento en la sensibilidad a la insulina mas adelante en la vida.Info
- Publication number
- MX2016006882A MX2016006882A MX2016006882A MX2016006882A MX2016006882A MX 2016006882 A MX2016006882 A MX 2016006882A MX 2016006882 A MX2016006882 A MX 2016006882A MX 2016006882 A MX2016006882 A MX 2016006882A MX 2016006882 A MX2016006882 A MX 2016006882A
- Authority
- MX
- Mexico
- Prior art keywords
- life
- improvement
- insulin sensitivity
- infant nutrition
- later
- Prior art date
Links
- 206010022489 Insulin Resistance Diseases 0.000 title 1
- 235000021125 infant nutrition Nutrition 0.000 title 1
- 235000016709 nutrition Nutrition 0.000 abstract 2
- 208000001145 Metabolic Syndrome Diseases 0.000 abstract 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 abstract 1
- 239000005018 casein Substances 0.000 abstract 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 abstract 1
- 235000021240 caseins Nutrition 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1524—Inert gases, noble gases, oxygen, aerosol gases; Processes for foaming
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Diabetes (AREA)
- Nutrition Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Immunology (AREA)
- Pediatric Medicine (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Physiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
La presente invención se refiere a una composición nutritiva para usarse en el tratamiento, la prevención y/o la reducción del riesgo de un trastorno de síndrome metabólico que aparece más adelante en la vida, en donde la composición nutritiva comprende caseína.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13195014 | 2013-11-29 | ||
PCT/EP2014/075831 WO2015078974A1 (en) | 2013-11-29 | 2014-11-27 | Infant nutrition for improvement in insulin sensitivity later in life |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2016006882A true MX2016006882A (es) | 2016-08-17 |
Family
ID=49679400
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2016006882A MX2016006882A (es) | 2013-11-29 | 2014-11-27 | Nutricion infantil para el mejoramiento en la sensibilidad a la insulina mas adelante en la vida. |
Country Status (8)
Country | Link |
---|---|
US (1) | US10821150B2 (es) |
EP (1) | EP3082472A1 (es) |
CN (1) | CN105578904A (es) |
AU (1) | AU2014356485A1 (es) |
MX (1) | MX2016006882A (es) |
PH (1) | PH12016500950A1 (es) |
RU (1) | RU2694827C1 (es) |
WO (1) | WO2015078974A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2017251143B2 (en) * | 2016-04-11 | 2021-05-20 | Société des Produits Nestlé S.A. | Infant nutrition delivering metabolic benefits |
MX2021005668A (es) * | 2018-11-30 | 2021-06-15 | Nestle Sa | Composicion nutricional infantil para usar en el mejoramiento de la maduracion pancreatica y la biosintesis de insulina. |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002083164A2 (en) * | 2001-04-10 | 2002-10-24 | Societe Des Produits Nestle S.A. | Method and composition for prophylaxis of diabetes |
WO2008054192A1 (en) * | 2006-11-02 | 2008-05-08 | N.V. Nutricia | Use of nutritional compositions for preventing disorders |
EP1932437A1 (en) * | 2006-12-15 | 2008-06-18 | Nestec S.A. | Infant formula |
EP2011506A1 (en) * | 2007-07-05 | 2009-01-07 | Nestec S.A. | Supplementation of maternal diet |
PL2341784T3 (pl) | 2008-09-02 | 2013-03-29 | Nutricia Nv | Kompozycje odżywcze z powleczonymi globulkami lipidowymi |
RU2559646C2 (ru) | 2009-04-01 | 2015-08-10 | Нестек С.А. | Снижение риска ожирения |
RU2011144581A (ru) | 2009-04-03 | 2013-05-10 | Нестек С.А. | Улучшение стимулирования здоровья при "догоняющем росте" |
WO2010119088A2 (en) * | 2009-04-15 | 2010-10-21 | Bodo Melnik | Milk and milk-based products modified to exhibit a reduced insulinemic index and/or reduced mitogenic activity |
EP2583562A1 (en) | 2011-10-21 | 2013-04-24 | Nestec S.A. | Use of whey protein micelles for infants at risk of obesity or diabetes |
CN104302192A (zh) | 2011-12-27 | 2015-01-21 | 雅培制药有限公司 | 具有特定的乳清与酪蛋白比的热量减少型婴儿配方产品 |
-
2014
- 2014-11-27 US US15/100,427 patent/US10821150B2/en active Active
- 2014-11-27 AU AU2014356485A patent/AU2014356485A1/en not_active Abandoned
- 2014-11-27 WO PCT/EP2014/075831 patent/WO2015078974A1/en active Application Filing
- 2014-11-27 CN CN201480052640.5A patent/CN105578904A/zh active Pending
- 2014-11-27 RU RU2016125907A patent/RU2694827C1/ru active
- 2014-11-27 MX MX2016006882A patent/MX2016006882A/es unknown
- 2014-11-27 EP EP14803141.2A patent/EP3082472A1/en not_active Withdrawn
-
2016
- 2016-05-23 PH PH12016500950A patent/PH12016500950A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
RU2694827C1 (ru) | 2019-07-17 |
US20160296585A1 (en) | 2016-10-13 |
PH12016500950A1 (en) | 2016-06-27 |
US10821150B2 (en) | 2020-11-03 |
EP3082472A1 (en) | 2016-10-26 |
WO2015078974A1 (en) | 2015-06-04 |
AU2014356485A1 (en) | 2016-03-03 |
CN105578904A (zh) | 2016-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ750707A (en) | Cot modulators and methods of use thereof | |
MX2015008114A (es) | Derivados de exendina-4. | |
MX2014015423A (es) | Analogos de peptido de exedina-4. | |
PH12016500774A1 (en) | Nutritional composition for use in reducing metabolic stress in infants, decreasing gut permeability and approximating growth rate of breast-fed infants | |
PH12017500052A1 (en) | Myo-inositol and probiotics and uses | |
PH12017501290A1 (en) | Treatment of pediatric type 2 diabetes mellitus patients with lixisenatide | |
MX2017002796A (es) | Tasimelteon para tratar el sindrome de smith-magenis. | |
PH12017500017A1 (en) | A combination of vitamin d and zinc and its use | |
PH12014502071A1 (en) | Beta-hydroxy-beta-methylbutyric acid for imrpoving glucose tolerance | |
MX362070B (es) | Polioles que contienen tanino, su producción y su uso. | |
WO2014147503A3 (en) | Anti-bag3 antibodies for therapeutic use | |
PH12019550209A1 (en) | A nutritional composition for use to enhance attention and/or reduce impulsivity | |
PH12016501867A1 (en) | Gender specific synthetic nutritional compositions and nutritional systems comprising them | |
PH12016501868A1 (en) | Gender specific synthetic nutritional compositions and nutritional systems comprising them | |
PH12016500950A1 (en) | Infant nutrition for improvement in insulin sensitivity later in life | |
PH12016501947B1 (en) | Gender specific synthetic nutritional compositions and nutritional systems comprising them | |
PH12017500084A1 (en) | Vitamin b2 and its use | |
PH12016501817A1 (en) | Gender specific synthetic nutritional compositions and nutritional systems comprising them | |
MX2015009161A (es) | Polioles, su preparación y su uso. | |
MX345908B (es) | Sistema de energía comestible. | |
PH12016501919B1 (en) | Gender specific synthetic nutritional compositions and nutritional systems comprising them | |
PH12016501918B1 (en) | Gender specific synthetic nutritional compositions and nutritional systems comprising them | |
PH12016501920A1 (en) | Gender specific synthetic nutritional compositions and nutritional systems comprising them | |
MX2016015137A (es) | Composiciones nutricionales sinteticas especificas del modo de parto y sistemas que las comprenden. | |
MX2015017136A (es) | Composicion para la administracion oral de magnesio, en asociacion con una composicion para tratar la diabetes tipo 2 o las complicaciones de la misma. |